ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
31.47
-0.02 (-0.06%)
Nov 5, 2024, 1:18 PM EST - Market open

ArriVent BioPharma Analyst Ratings

Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$36.80
Upside
+16.94%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
Citigroup
Citigroup
Strong Buy
Maintains
$30$36
Strong Buy Maintains $30$36 +14.39% Sep 11, 2024
Oppenheimer
Oppenheimer
Buy
Reiterates
$35$39
Buy Reiterates $35$39 +23.93% Sep 10, 2024
Goldman Sachs
Goldman Sachs
Strong Buy
Maintains
$28$38
Strong Buy Maintains $28$38 +20.75% Sep 10, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$30$36
Strong Buy Maintains $30$36 +14.39% Sep 10, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$25$30
Strong Buy Maintains $25$30 -4.67% Aug 16, 2024
Oppenheimer
Oppenheimer
Buy
Reiterates
$35
Buy Reiterates $35 +11.22% Aug 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$25
Strong Buy Reiterates $25 -20.56% Jun 6, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$25
Strong Buy Reiterates $25 -20.56% May 9, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$25
Strong Buy Initiates $25 -20.56% Apr 30, 2024
Citigroup
Citigroup
Strong Buy
Initiates
$30
Strong Buy Initiates $30 -4.67% Feb 20, 2024
Jefferies
Jefferies
Strong Buy
Initiates
$35
Strong Buy Initiates $35 +11.22% Feb 20, 2024
Goldman Sachs
Goldman Sachs
Strong Buy
Initiates
$27
Strong Buy Initiates $27 -14.20% Feb 20, 2024